These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15049992)

  • 21. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ; Wilton LV; Shakir SA
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
    Jackson G; Montorsi P; Cheitlin MD
    Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction.
    Ichikawa T; Takao A; Manabe D; Saegusa M; Tanimoto R; Aramaki K; Yamamoto M; Okazaki T
    Int J Urol; 2004 Sep; 11(9):755-62. PubMed ID: 15379940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)?
    Klotz T; Mathers M; Klotz R; Sommer F
    Int J Impot Res; 2005; 17(1):2-4. PubMed ID: 15201860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sildenafil--adverse effects, complications and safety].
    Sperling H; Michel MC
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):4-6. PubMed ID: 12407928
    [No Abstract]   [Full Text] [Related]  

  • 29. The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England.
    Twaites BR; Wilton LV; Shakir SA
    J Psychopharmacol; 2007 Jun; 21(4):392-9. PubMed ID: 17656426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of sildenafil on erectile dysfunction in the aged men with diabetes].
    He ZJ; Jin J; Zhang K
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):841-2, 846. PubMed ID: 16333965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of nateglinide as used in general practice in England: results of a prescription-event monitoring study.
    Twaites B; Wilton LV; Layton D; Shakir SA
    Acta Diabetol; 2007 Dec; 44(4):233-9. PubMed ID: 17874223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction.
    Fujisawa M; Sawada K
    Arch Androl; 2004; 50(4):255-60. PubMed ID: 15277003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus.
    Israilov S; Shmuely J; Niv E; Engelstein D; Livne P; Boniel J
    Int J Impot Res; 2005; 17(5):431-6. PubMed ID: 15889124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function.
    Son H; Park K; Kim SW; Paick JS
    Asian J Androl; 2004 Jun; 6(2):117-20. PubMed ID: 15154085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000.
    Boshier A; Wilton LV; Shakir SA
    Eur J Clin Pharmacol; 2003 Dec; 59(10):767-73. PubMed ID: 14615857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety profile of orlistat: results of a prescription-event monitoring study.
    Acharya NV; Wilton LV; Shakir SA
    Int J Obes (Lond); 2006 Nov; 30(11):1645-52. PubMed ID: 16552401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure.
    Katz SD; Parker JD; Glasser DB; Bank AJ; Sherman N; Wang H; Sweeney M
    Am J Cardiol; 2005 Jan; 95(1):36-42. PubMed ID: 15619391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil in the treatment of erectile dysfunction in men with diabetes: demand, efficacy and patient satisfaction.
    Behrend L; Vibe-Petersen J; Perrild H
    Int J Impot Res; 2005; 17(3):264-9. PubMed ID: 15674401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
    Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
    BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.